Improved outcomes of UM171–expanded cord blood transplantation compared with other graft sources: real-world evidence

Cord blood (CB) transplantation is hampered by low cell dose and high nonrelapse mortality (NRM). A phase 1-2 trial of UM171-expanded CB transplants demonstrated safety and favorable preliminary efficacy. The aim of the current analysis was to retrospectively compare results of the phase 1-2 trial w...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Sandra, Bambace, Nadia, Ahmad, Imran, Roy, Jean, Tang, Xiaoying, Zhang, Mei-Jie, Burns, Linda, Barabé, Frédéric, Bernard, Léa, Delisle, Jean-Sébastien, Kiss, Thomas, Lachance, Silvy, Roy, Denis-Claude, Veilleux, Olivier, Sauvageau, Guy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539875/
https://www.ncbi.nlm.nih.gov/pubmed/37467030
http://dx.doi.org/10.1182/bloodadvances.2023010599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539875/
https://www.ncbi.nlm.nih.gov/pubmed/37467030
http://dx.doi.org/10.1182/bloodadvances.2023010599

Ejemplares similares